Skip to main content
Clinical Trials/NCT00425568
NCT00425568CompletedNot Applicable

Phase I Study of Transdermal Testosterone Gel and Its Effect on Erection Quality as Measured by a Digital Inflection Rigidometer (DIR)

Lamm, Steven, M.D.1 site in 1 country30 target enrollmentStarted: December 2005Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
1

Study Overview

Brief Summary

Low testosterone may be responsible for "soft" erections in men. The purpose of our study is to see whether the daily application of a testosterone gel to raise testosterone levels will also increase the "hardness" of a man's erection.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
21 Years to 59 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Testosterone <350 ng/dL,
  • 21-59 years of age,

Exclusion Criteria

  • Those with carcinoma of the breast or known or suspected carcinoma of the prostate or with known hypersensitivity to any of the ingredients in AndroGel.
  • Men will be excluded if they have unstable angina, hypertension, diabetes, heart failure, or coronary artery disease.
  • Men will agree to discontinue use of current testosterone replacement, as well as Viagra or any other PDE5 inhibitors for 30 days.

Investigators

Sponsor
Lamm, Steven, M.D.
Sponsor Class
Indiv

Study Sites (1)

Loading locations...

Similar Trials